TR200102019T2 - 3-izoksazolidinonların ve hidroksilamik asitlerin enfeksiyonların tedavisinde kullanılmaları. - Google Patents

3-izoksazolidinonların ve hidroksilamik asitlerin enfeksiyonların tedavisinde kullanılmaları.

Info

Publication number
TR200102019T2
TR200102019T2 TR2001/02019T TR200102019T TR200102019T2 TR 200102019 T2 TR200102019 T2 TR 200102019T2 TR 2001/02019 T TR2001/02019 T TR 2001/02019T TR 200102019 T TR200102019 T TR 200102019T TR 200102019 T2 TR200102019 T2 TR 200102019T2
Authority
TR
Turkey
Prior art keywords
treatment
infections
hydroxylamic
isoxazolidinones
acids
Prior art date
Application number
TR2001/02019T
Other languages
English (en)
Turkish (tr)
Inventor
Jomaa Hassan
Original Assignee
Jomaa Pharmaka Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19903666A external-priority patent/DE19903666A1/de
Application filed by Jomaa Pharmaka Gmbh filed Critical Jomaa Pharmaka Gmbh
Publication of TR200102019T2 publication Critical patent/TR200102019T2/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/164Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06Antimalarials
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
TR2001/02019T 1999-01-13 2000-01-12 3-izoksazolidinonların ve hidroksilamik asitlerin enfeksiyonların tedavisinde kullanılmaları. TR200102019T2 (tr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19900907 1999-01-13
DE19903666A DE19903666A1 (de) 1999-01-13 1999-01-30 Arzneimittel mit einem Gehalt an 3-Isoxazolidinonen und Hydroxylaminsäuren als Wirkstoff und ihre Verwendung

Publications (1)

Publication Number Publication Date
TR200102019T2 true TR200102019T2 (tr) 2002-04-22

Family

ID=26051290

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/02019T TR200102019T2 (tr) 1999-01-13 2000-01-12 3-izoksazolidinonların ve hidroksilamik asitlerin enfeksiyonların tedavisinde kullanılmaları.

Country Status (14)

Country Link
EP (1) EP1143941A3 (xx)
JP (1) JP2002534440A (xx)
CN (1) CN1342078A (xx)
AU (1) AU2436600A (xx)
BR (1) BR0007491A (xx)
CA (1) CA2360366A1 (xx)
CZ (1) CZ20012380A3 (xx)
HU (1) HUP0105412A2 (xx)
IL (1) IL143795A0 (xx)
NO (1) NO20013464L (xx)
PL (1) PL350128A1 (xx)
SK (1) SK9502001A3 (xx)
TR (1) TR200102019T2 (xx)
WO (1) WO2000041473A2 (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7022705B2 (en) 2001-10-25 2006-04-04 Astrazeneca Ab Isoxazoline derivatives useful as antimicrobials
GB202209172D0 (en) * 2022-06-22 2022-08-10 Syngenta Crop Protection Ag Improvements in or relating to organic compounds

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL45174A (en) * 1973-08-10 1976-12-31 Merck & Co Inc Antibacterial preparations containing a compound of the type 3-fluoro-D-alanine and a cyclocarrin compound that is converted in the nitrogen atom
US3911007A (en) * 1974-08-08 1975-10-07 Searle & Co N-substituted N-benzyloxy-2-methyl-2-(4-halophenoxy)propionamides
FR2290442A1 (fr) * 1974-11-06 1976-06-04 Aries Robert Nouvelles rifamycines
DE3686632T2 (de) * 1985-04-30 1993-01-21 Takeda Chemical Industries Ltd Antibiotische derivate, ihre herstellung und verwendung.
GB8531838D0 (en) * 1985-12-30 1986-02-05 Wellcome Found Aryl derivatives
JPS63119462A (ja) * 1986-11-05 1988-05-24 Takeda Chem Ind Ltd 五員環n−スルホ化合物
JPS63119476A (ja) * 1986-11-05 1988-05-24 Takeda Chem Ind Ltd イソキサゾリドン誘導体
US5288896A (en) * 1992-01-15 1994-02-22 Warner-Lambert Company 3,5-di-t-butyl-4-hydroxylphenylmethylhydroxylamines and their derivatives, pharmaceutical compositions, and methods of use therefor
AU671724B2 (en) * 1993-03-16 1996-09-05 British Biotech Pharmaceuticals Limited Hydroxamic acid derivatives as metalloproteinase inhibitors
NZ271893A (en) * 1993-08-23 1997-11-24 Immunex Corp Inhibitors of tnf-alpha secretion
GB9401129D0 (en) * 1994-01-21 1994-03-16 British Bio Technology Hydroxamic acid derivatives as metalloproteinase inhibitors
WO1996013263A2 (en) * 1994-11-01 1996-05-09 Research Corporation Technologies, Inc. Methods of treatment of viral disease with inhibitors of sphingolipid biosynthesis
US5919790A (en) * 1996-10-11 1999-07-06 Warner-Lambert Company Hydroxamate inhibitors of interleukin-1β converting enzyme
EP0971895A1 (en) * 1997-03-28 2000-01-19 AstraZeneca AB Hydroxamic acids substituted by heterocycles useful for inhibition of tumor necrosis factor
AUPO721997A0 (en) * 1997-06-06 1997-07-03 Queensland Institute Of Medical Research, The Anticancer compounds

Also Published As

Publication number Publication date
PL350128A1 (en) 2002-11-04
NO20013464L (no) 2001-09-12
CZ20012380A3 (cs) 2002-01-16
BR0007491A (pt) 2001-11-20
NO20013464D0 (no) 2001-07-12
HUP0105412A2 (hu) 2002-05-29
IL143795A0 (en) 2002-04-21
EP1143941A3 (de) 2002-02-06
CA2360366A1 (en) 2000-07-20
JP2002534440A (ja) 2002-10-15
EP1143941A2 (de) 2001-10-17
CN1342078A (zh) 2002-03-27
WO2000041473A2 (de) 2000-07-20
WO2000041473A3 (de) 2001-11-29
SK9502001A3 (en) 2002-05-09
AU2436600A (en) 2000-08-01

Similar Documents

Publication Publication Date Title
ATE303993T1 (de) 4-hydroxychinolin-3-carboxamide und hydrazide als antivirale wirkstoffe
PT1073470E (pt) Composicoes farmaceuticas contendo compostos com actividade capaz de melhorar a absorcao de ingredientes activos
ATE232862T1 (de) Oxazolidinon derivate und diese enthaltende pharmazeutische zusammensetzungen
DE122006000014I1 (de) Pyranonverbindungenzur Behandlung retroviraler Infektionen
ES2172585T3 (es) Derivado de benzoimidazol.
TR200402704T4 (tr) Yeni fenil-propargileter türevleri
TR200101499T1 (tr) Azepinoindol türevleri, hazırlanmaları ve kullanımları.
YU48701A (sh) Fenilfenantridini sa dejstvom inhibicije pde-iv
AP2000001942A0 (en) Use of organophosphoric compounds for the therapeutic and preventative treatment of infections.
ES2153975T3 (es) Derivados de pirimidona con actividad antifungica.
TR200101124T2 (tr) N-(2-aril-propiyonil)-sülfonamidler ve bunları içeren farmasötik preparasyonlar.
TR200200883T2 (tr) 2-ikameli 1,1-bifenil-2-karbonamidler, imalat yöntemleri, ilaç olarak kullanılmaları
AR014554A1 (es) Compuestos polipeptidos, utiles para el tratamiento de infecciones microbianas, procedimiento para prepararlos, composiciones y medicamentos quelos incluyen y el uso de dichos compuestos y metodo para el tratamiento profilactico y terapeutico de infecciones
TR200101649T2 (tr) Piperazin türevleri.
BR0001201A (pt) Composto ( poli ) tia-alcinóicos, composição cosmética, utilização de uma composição cosmética, utilização de um composto e composição farmacêutica
TR200101979T2 (tr) Antidepresyon tedavisi için 5HT1 antagonistleri.
TR200101841T2 (tr) Enfeksiyonlardan korunmak ve enfeksiyon tedavisi için bifosfonatların kullanılmaları
DE50011645D1 (de) Sphingomyelinase inhibitoren als wirkstoffe mit antiapoptotischer und antiseptischer wirkung
TR200102019T2 (tr) 3-izoksazolidinonların ve hidroksilamik asitlerin enfeksiyonların tedavisinde kullanılmaları.
FR2768145B1 (fr) Nouveaux composes derives d'acide alkylene diamine di- ou tri-acetique, leur procede de preparation, leur utilisation dans des compositions cosmetiques et pharmaceutiques, et compositions les comprenant
DE59403472D1 (de) Mikrobizide mittel
TR200103212T2 (tr) Mantar ilacı olarak kullanılan eterler
DE60003074D1 (de) Fusidinsäure-derivate
ATE247649T1 (de) Disubstituierte biphenyloxazoline
TR199801835A2 (xx) Antimikrobiyal kompozisyonlar.